SAGLENCEgroup
Scouting technologies. Shaping futures.
We identify and acquire promising technologies with high market potential and support founders on the path from innovation to strategic funding and growth capital.
We identify and acquire promising technologies with high market potential and support founders on the path from innovation to strategic funding and growth capital.
We focus on asset-heavy IP with defensible competitive moats. Whether it's a university patent on a novel therapeutic or a proprietary enterprise platform.
Preclinical therapeutics with granted patents from top research universities. Exclusive licenses on novel molecules, biologics, gene therapies, and platform technologies with clear regulatory pathways.
Advanced materials, energy technology, quantum computing applications, robotics, and industrial automation. Technologies with strong patent portfolios and defensible technical advantages.
B2B platforms with proven traction: ERP, CRM, workflow automation, BI, and low-code solutions. Companies with $1M+ ARR, clean financials, and readiness for institutional capital.
We don't just find technologies. We build companies with a funded path through every stage: private rounds, IPO, follow-on offerings, and strategic partnerships.
Term Sheet Signed
Term sheet agreed. IP holder receives initial payment. Deal structure confirmed.
License Acquired
Exclusive license executed. Team receives funding to continue R&D. We begin IPO preparation in parallel.
IPO Preparation
Science team focuses on data, we handle everything else. S-1 filing, audit, SEC review, roadshow preparation.
NASDAQ IPO
IPO closes. Capital raised funds next development stage. IP holders receive equity upside.
Post-IPO Growth
Clinical milestones drive share price. Additional capital raised via secondary offerings for subsequent stages.
Equity liquidity through public listing. Milestone payments and royalties. Full financial transparency via SEC reporting. Your innovation: funded, developed, and brought to market.
Private round entry at pre-IPO valuation. NASDAQ liquidity. Pro-rata follow-on rights. Institutional-grade compliance and reporting from day one.
Meaningful equity and advisory roles. Continuous funding eliminates development gaps. Dedicated management support lets you focus on what you do best.
Focused, data-driven support for founders and shareholders ready to scale or exit.
We discover high-potential technologies and teams before they become obvious to the market, building a qualified pipeline aligned with your strategy.
From target screening to negotiation and diligence. We structure deals, coordinate workstreams, and de-risk integration.
Investor readiness, narrative, KPIs and board materials. We help founders prepare and execute growth financing with disciplined execution.
A structured, hands-on approach that turns promising technologies and teams into funded, growing, publicly-listed businesses.
We source opportunities across university labs, patent portfolios, startup ecosystems, and growth-stage tech companies. Then we run deep diligence before committing.
Great technology needs great people. We assemble management teams, advisory boards, and domain experts tailored to each company's stage and sector.
We work hands-on with portfolio companies: building product, entering markets, and hitting the milestones that unlock each next stage of growth.
End-to-end capital strategy: from early private rounds through NASDAQ listing and follow-on offerings that keep growth funded without interruption.
Just share what you're building or aiming for. We'll reply with how we might help.
Contact us